Valuation: Center Laboratories, Inc.

Market Cap 29.08B 906M 792M 731M 675M 1.28B 86.41B 1.3B 8.73B 3.43B 42.57B 3.4B 3.33B 146B P/E 2024
-28.2x
P/E 2025 3.64x
Enterprise Value 33.12B 1.03B 903M 833M 769M 1.46B 98.42B 1.48B 9.95B 3.91B 48.48B 3.87B 3.79B 167B EV / Sales 2024
22.3x
EV / Sales 2025 23.1x
Free-Float
73.35%
Yield 2024
1.71%
Yield 2025 4.21%
1 day-1.02%
1 week+1.43%
Current month+2.10%
1 month+3.04%
3 months-1.89%
6 months-4.77%
Current year-6.37%
1 week 38.75
Extreme 38.75
40.55
1 month 36.8
Extreme 36.8
40.55
Current year 36.8
Extreme 36.8
51.4
1 year 33.1
Extreme 33.1
51.4
3 years 29.12
Extreme 29.1236
58.79
5 years 29.12
Extreme 29.1236
58.79
10 years 20.99
Extreme 20.9884
64.21
Manager TitleAgeSince
Chief Executive Officer - 02/08/1998
Director of Finance/CFO - 07/12/2022
Chief Tech/Sci/R&D Officer - 30/06/1983
Director TitleAgeSince
Chairman - 29/11/2022
Director/Board Member 61 13/06/2010
Director/Board Member - 13/06/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%+1.43%+11.66%-20.38% 903M
-2.72%-1.26%+49.87%+161.49% 1,085B
-1.06%-1.02%+62.77%+60.91% 624B
-1.46%-3.33%+26.30%+83.12% 442B
+0.33%-1.17%+27.98%+26.90% 332B
-3.89%-11.22%+20.78%+26.07% 277B
-0.02%-2.85%+25.27%+44.88% 282B
+0.66%-1.42%-29.26%-39.30% 217B
-0.56%-1.18%+20.56%+61.14% 196B
-3.67%+0.62%+13.86%+72.31% 167B
Average -1.41%-1.86%+22.98%+47.71% 362.28B
Weighted average by Cap. -1.67%-1.06%+35.08%+81.24%

Financials

2024 2025
Net sales 1.62B 50.41M 44.09M 40.67M 37.56M 71.27M 4.81B 72.47M 486M 191M 2.37B 189M 185M 8.14B 1.52B 47.24M 41.32M 38.11M 35.2M 66.79M 4.51B 67.92M 455M 179M 2.22B 177M 174M 7.63B
Net income -1.1B -34.39M -30.08M -27.74M -25.62M -48.62M -3.28B -49.44M -331M -130M -1.62B -129M -126M -5.55B 9.32B 290M 254M 234M 216M 411M 27.7B 418M 2.8B 1.1B 13.65B 1.09B 1.07B 46.92B
Net Debt 4.48B 140M 122M 113M 104M 197M 13.31B 201M 1.35B 528M 6.56B 524M 513M 22.55B 4.04B 126M 110M 102M 93.83M 178M 12.01B 181M 1.21B 477M 5.92B 473M 462M 20.34B
Logo Center Laboratories, Inc.
Center Laboratories Inc is a Taiwan-based company engaged in the development of pharmaceutical products. The Company's products mainly focus on internal liquids, including syrups, suspensions, liquids and other dosage forms. Pharmacological classifications include respiratory tract therapeutics such as cough suppressants, sputum expectorants, asthma medications, and runny nose relief, while antipyretic and analgesic medications and gastrointestinal medications are also in great demand, and a variety of internal liquids and lozenges for the treatment of central nervous system (CNS) such as epilepsy, dysphoria, dementia, and Parkinson's disease have already been introduced into the market. The Company is a specialized manufacturer of internal liquid.
Employees
-
Date Price Change Volume
09/07/26 NT$38.95 -1.02% 1,354,313
08/07/26 NT$39.35 -0.38% 2,447,035
07/07/26 NT$39.50 -0.75% 2,544,596
06/07/26 NT$39.80 +0.38% 4,071,591
03/07/26 NT$39.65 +3.26% 8,219,167
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. 4123 Stock